CONTRIBUTORS Contributors
Alan J. Budney, PhD, Associate Professor, University of Vermont Treatment Research Center, South Burlington, Vermont. Claire D. Coles, PhD, Emory University School of Medicine, Department of Psychiatry–Genetics, Georgia Mental Health Institute, Atlanta, Georgia. Fulton T. Crews, PhD, Professor of Pharmacology and Psychiatry, Director, Center for Alcohol Studies, Bowles Center for Alcohol Studies, Pharmacology and Psychiatry School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Carlton K. Erickson, PhD, Director, Addiction Science Research and Education Center, and Pfizer Centennial Professor of Pharmacology, University of Texas at Austin College of Pharmacy, Austin, Texas. Corinne E. Frantz, PhD, Clinical Neuropsychologist, Maplewood, New Jersey. Karen K. Howell, PhD, Maternal Substance Abuse and Child Development Project, Emory University School of Medicine, Department of Psychiatry–Genetics, Georgia Mental Health Institute, Atlanta, Georgia. Julie Kable, PhD, Emory University School of Medicine, Department of Psychiatry–Genetics, Georgia Mental Health Institute, Atlanta, Georgia. Paul Kolecki, MD, Assistant Professor, Department of Surgery, Division of Emergency Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania. Mary Jeanne Kreek, MD, Professor and Head, Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, New York. Anthony S. Manoguerra, PharmD, DABAT, FAACT, Professor of Clinical Pharmacy, San Diego Program, School of Pharmacy, University of California at San Francisco, San Francisco, California, and Director, San Diego Division, California Poison Control System, San Diego, California. Sarah N. Mattson, PhD, Associate Director, Center for Behavioral Teratology, San Diego, California.